Qian Zhang1, Michael Murawsky1, Terri LaCount1, Jinsong Hao2, Gerald B Kasting1, Bryan Newman3, Priyanka Ghosh3, Sam G Raney3, S Kevin Li4. 1. Division of Pharmaceutical Sciences, College of Pharmacy, University of Cincinnati, 231 Albert Sabin Way, MSB # 3005, Cincinnati, Ohio, 45267-0514, USA. 2. Department of Pharmaceutical Science and Research, School of Pharmacy, Marshall University, Huntington, West Virginia, 25755, USA. 3. Division of Therapeutic Performance, Office of Research and Standards, Office of Generic Drugs, U.S. Food and Drug Administration, Silver Spring, Maryland, 20993, USA. 4. Division of Pharmaceutical Sciences, College of Pharmacy, University of Cincinnati, 231 Albert Sabin Way, MSB # 3005, Cincinnati, Ohio, 45267-0514, USA. kevin.li@uc.edu.
Abstract
PURPOSE: Performance of a transdermal delivery system (TDS) can be affected by exposure to elevated temperature, which can lead to unintended safety issues. This study investigated TDS and skin temperatures and their relationship in vivo, characterized the effective thermal resistance of skin, and identified the in vitro diffusion cell conditions that would correlate with in vivo observations. METHODS: Experiments were performed in humans and in Franz diffusion cells with human cadaver skin to record skin and TDS temperatures at room temperature and with exposure to a heat flux. Skin temperatures were regulated with two methods: a heating lamp in vivo and in vitro, or thermostatic control of the receiver chamber in vitro. RESULTS: In vivo basal skin temperatures beneath TDS at different anatomical sites were not statistically different. The maximum tolerable skin surface temperature was approximately 42-43°C in vivo. The temperature difference between skin surface and TDS surface increased with increasing temperature, or with increasing TDS thermal resistance in vivo and in vitro. CONCLUSIONS: Based on the effective thermal resistance of skin in vivo and in vitro, the heating lamp method is an adequate in vitro method. However, the in vitro-in vivo correlation of temperature could be affected by the thermal boundary layer in the receiver chamber.
PURPOSE: Performance of a transdermal delivery system (TDS) can be affected by exposure to elevated temperature, which can lead to unintended safety issues. This study investigated TDS and skin temperatures and their relationship in vivo, characterized the effective thermal resistance of skin, and identified the in vitro diffusion cell conditions that would correlate with in vivo observations. METHODS: Experiments were performed in humans and in Franz diffusion cells with human cadaver skin to record skin and TDS temperatures at room temperature and with exposure to a heat flux. Skin temperatures were regulated with two methods: a heating lamp in vivo and in vitro, or thermostatic control of the receiver chamber in vitro. RESULTS: In vivo basal skin temperatures beneath TDS at different anatomical sites were not statistically different. The maximum tolerable skin surface temperature was approximately 42-43°C in vivo. The temperature difference between skin surface and TDS surface increased with increasing temperature, or with increasing TDS thermal resistance in vivo and in vitro. CONCLUSIONS: Based on the effective thermal resistance of skin in vivo and in vitro, the heating lamp method is an adequate in vitro method. However, the in vitro-in vivo correlation of temperature could be affected by the thermal boundary layer in the receiver chamber.
Entities:
Keywords:
heat effect; in vitro permeation test (IVPT); temperature; transdermal; transdermal delivery system (TDS)
Authors: A Bur; C Joukhadar; N Klein; G Mitulovic; R Schmid; E Agneter; M Müller; M Brunner Journal: Int J Clin Pharmacol Ther Date: 2005-05 Impact factor: 1.366
Authors: Suneela Prodduturi; Nakissa Sadrieh; Anna M Wokovich; William H Doub; Benjamin J Westenberger; Lucinda Buhse Journal: J Pharm Sci Date: 2010-05 Impact factor: 3.534
Authors: Qian Zhang; Michael Murawsky; Terri D LaCount; Jinsong Hao; Priyanka Ghosh; Sam G Raney; Gerald B Kasting; S Kevin Li Journal: J Pharm Sci Date: 2020-07-20 Impact factor: 3.534
Authors: Terri D La Count; Qian Zhang; Michael Murawsky; Jinsong Hao; Priyanka Ghosh; Kaushalkumar Dave; Sam G Raney; Arjang Talattof; Gerald B Kasting; S Kevin Li Journal: AAPS J Date: 2020-06-02 Impact factor: 4.009
Authors: Terri D LaCount; Qian Zhang; Jinsong Hao; Priyanka Ghosh; Sam G Raney; Arjang Talattof; Gerald B Kasting; S Kevin Li Journal: AAPS J Date: 2020-05-10 Impact factor: 4.009